Zu "294646-77-8" wurden 5 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
(R)-CR8
(R)-CR8

Artikelnummer: Cay14006-10

Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy. (R)-CR8 is a second-generation analog of (R)-roscovitine (Cay-10009569) that inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk9/cyclin T with IC50 values of 0.09,...
Schlagworte: 2R-[[9-(1-methylethyl)-6-[[[4-(2-pyridinyl)phenyl]methyl]amino]-9H-purin-2-yl]amino]-1-butanol
Anwendung: CDK Inhibitor
CAS 294646-77-8
MW: 431.5 D
ab 77,00 €
Bewerten
(R)-CR8
(R)-CR8

Artikelnummer: AG-CR1-0039-M001

Potent and selective cyclin-dependent kinase (CDK) 1, 2, 5, 7 and 9 inhibitor, Apoptosis inducer, Potent glycogen synthase kinase (GSK-3alpha/beta) inhibitor.
Schlagworte: 2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-(4-(2-pyridyl)benzyl)-9-isopropylpurine
Anwendung: CDK inhibitor
CAS 294646-77-8
MW: 431,5 D
ab 50,00 €
Bewerten
(S)-CR8
(S)-CR8

Artikelnummer: AG-CR1-0040-M005

Potent and selective cyclin-dependent kinase (CDK) 1, 2, 5, 7 and 9 inhibitor, Apoptosis inducer, Glycogen synthase kinase (GSK-3alpha/beta) inhibitor.
Schlagworte: 2-(S)-(1-Ethyl-2-hydroxyethylamino)-6-(4-(2-pyridyl)benzyl)-9-isopropylpurine
Anwendung: CDK inhibitor
CAS 294646-77-8
MW: 431,5 D
ab 50,00 €
Bewerten
(R)-CR8
(R)-CR8

Artikelnummer: AG-MR-C0003-M010

Soluble in DMSO or ethanol. Stock solutions can be made up to 10 mM in DMSO. Potent and selective inhibitor of cyclin dependent kinases CDK1, CDK2, CDK5, CDK7 and CDK9. Apoptosis inducer. Inhibits the proliferation of various cancer cell lines. Casein kinase 1 (CK1delta/epsilon) and glycogen synthase kinase...
Schlagworte: 2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-(4-(2-pyridyl)benzyl)-9-isopropylpurine
Anwendung: Cyclin dependent kinase inhibitor
CAS 294646-77-8
MW: 431,5 D
ab 286,00 €
Bewerten
(R)-CR8
(R)-CR8

Artikelnummer: LKT-C6800.1

Roscovitine analog, CDK inhibitor.
Schlagworte: 2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-(4-(2-pyridyl)benzyl)-9-isopropylpurine
Anwendung: Roscovitine analog, CDK inhibitor
CAS 294646-77-8
MW: 431.54 D
ab 187,00 €
Bewerten